Is Victoza Better Than Bydureon?

Posted at 2nd December 2012 by Ryan Luce

written by Michael O’Leary

In a head-to-head comparison of the daily type 2 diabetes drug Victoza and weekly injections of Bydureon, those taking the daily drug did significantly better in lowering their HbA1c than those taking the weekly injections.

The down side was that those taking the higher than normal dose of Victoza had more side effects.

Good News For Potential Approval of Tresiba – A New Long-Acting Insulin

Posted at 25th November 2012 by Ryan Luce

written by Michael O’Leary

Last week an FDA advisory panel recommended degludec, a once-daily injectable insulin, be approved by the FDA, but will require Novo Nordisk to conduct additional trials to assess the heart risk that may be posed by the drug.

As reported by Fierce Biotech, Reuters and others the outside panel of non-FDA medical experts recommended approval by an 8-4 vote, but unanimously voted to require additional studies to assess the heart risk.
(published site)

Does losing weight help prevent heart attacks for people with type 2 diabetes?

Posted at 23rd October 2012 by Ryan Luce

written by Michael O’Leary

People with type 2 diabetes who maintained a weight-loss of 5 percent of their starting weight over four years saw improvements in blood sugar control, sleep apnea, mobility and HDL cholesterol.

Despite those benefits, however, researchers were surprised to find no difference in the rates of heart attacks, chest pain and death from cardiovascular causes between the exercise group and the comparison group of type 2 diabetes patients who did not lose weight.
(published site)

Does Qsymia Help Lower HbA1c? New Results From CONQUER Study

Posted at 16th October 2012 

written by Michael O’Leary

People with type 2 diabetes who participated in a study using a newly FDA-approved weight-loss drug reduced their blood sugar by an average of 0.4 percent compared to those in the trial who were taking a placebo.
(published site)

Is Weight Loss Surgery the Best Option to Prevent Type 2 Diabetes?

Posted at 30th August 2012 by Ryan Luce

written by Michael O’Leary

In a study that could lead to changes in doctors’ recommendations about weight-loss surgery for people at risk for type 2 diabetes, researchers have shown that the procedure may be twice as effective in preventing the disease as lifestyle changes.

(published site)

Why is Actos banned in France and Germany – but just made cheaper in U.S.?

Posted at 29th August 2012 by Ryan Luce

written by Michael O’Leary

Less than a week after France and Germany banned the use of pioglitazone, the FDA approved a generic version of the drug Actos for adults with type 2 diabetes.

As reported by Medpage Today, generic drug manufacturer Mylan Pharmaceticals was given approval for three dose levels of the drug, 15 mg, 30 mg and 45 mg. The approval comes just a year after the FDA approved updated labeling warning of bladder cancer risk for drug combinations using pioglitazone. The generic version will include the same warnings about heart failure and increased bladder cancer risk as the brand name versions.
(published site)

Can Curry Help Prevent Type 2 Diabetes?

Posted at 7th August 2012 by Ryan Luce

written by Michael O’Leary

A supplement containing one of the ingredients in curry spice has been reported to prevent new development of type 2 diabetes among people at high risk for the disease.

The study, appearing July 29, 2012 in the journal Diabetes Care was widely reported by a number of major news outlets, including Reuters, USA Today, and MSNBC, among others.
(published site)